Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 15/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9524915 | 0.84 | CYP3A4 (0.33) | CYP19A1PPARGALDH1A1L3MBTL1 | |
| SCHEMBL3798470 | 0.78 | CYP3A4 (0.33) | CYP19A1PPARGALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL27560805 | 0.78 | CYP3A4 (0.33) | CYP19A1PPARGALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL38982 | 0.78 | CYP3A4 (0.33) | CYP19A1PPARGALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL3224833 | 0.78 | CYP3A4 (0.33) | CYP19A1PPARGALDH1A1L3MBTL1CYP1A2 | |
| Hexadecane SCHEMBL28128441 | 0.78 | CYP3A4 (0.33) | CYP19A1PPARGALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL5616789 | 0.76 | CHRNB4 (0.33) | ALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL316918 | 0.74 | PPARG (0.34) | CYP19A1PPARGALDH1A1L3MBTL1CYP1A2 | |
| SCHEMBL28128514 | 0.74 | GNAO1 (0.33) | CYP19A1ALDH1A1L3MBTL1 | |
| SCHEMBL5567480 | 0.73 | CYP19A1 (0.31) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1620500-B1 | PHOTO-CURED AND STABILIZED COATINGS | BASF SE (DE) | 2012-07-11 | — | — | EP | disclosed |
| US-7790793-B2 | Amide nucleating agent compositions | CIBA SPECIALTY CHEM. CORP. (US) | 2010-09-07 | — | — | US | disclosed |
| EP-2016129-A1 | POLYMER ARTICLE MODIFIED WITH A METAL CATION CONTAINING COMPOUND | Ciba Holding Inc. (CH) | 2009-01-21 | — | — | EP | disclosed |
| WO-2007131919-A1 | POLYMER ARTICLE MODIFIED WITH A METAL CATION CONTAINING COMPOUND | CIBA HOLDING INC. (CH) | 2007-11-22 | — | — | WO | disclosed |
| US-20070149663-A1 | Resin compositions | CIBA SPECIALTY CHEMICALS CORP. | 2007-06-28 | — | — | US | disclosed |
| EP-1756211-A1 | POLYSTYRENE CONTAINING MASTERBATCH COMPOSITION FOR POLYESTER MODIFICATION | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-02-28 | — | — | EP | disclosed |
| US-20060252857-A1 | Aminoaryl-1-3-5-triazines and their use as uv absorbers | SCHAEFER THOMAS | 2006-11-09 | — | — | US | disclosed |
| WO-2005123820-A1 | POLYSTYRENE CONTAINING MASTERBATCH COMPOSITION FOR POLYESTER MODIFICATION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-12-29 | — | — | WO | disclosed |
| US-6525158-B1 | Preventing thermooxidative degradation; such as octadecyl ester of beta-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid, tris-(2,4-di-tert-butylphenyl)phosphite and calcium oxide | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-02-25 | — | — | US | disclosed |
| US-6380286-B1 | FOR STABILIZING AN ORGANIC MATERIAL WHICH IS SENSITIVE TO OXIDATIVE, THERMAL OR LIGHT-INDUCED DEGRADATION | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252857-A1 | Aminoaryl-1-3-5-triazines and their use as uv absorbers | IK, CRY2, CRY1 | CYP19A1 1009/4885PPARG 3912/4885ALDH1A1 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.